Andy Blackman

Email: andy.blackman@transcrip-partners.com

Andy is a pharmacovigilance professional with 16 years experience working within the area of Drug Safety. During this time he has worked in many different aspects of pharmacovigilance and led numerous teams within Drug Safety departments.

Prior to joining Transcrip, he worked for 12+ years within the Global Drug Safety Department of Roche Products Ltd., where latterly he led the Global Processing Department, which was responsible for processing approximately 100,000 single case reports per year. Whilst at Roche he contributed to several MHRA (PV, GCP, product specific) inspections and provided input and support during inspections by other regulatory authorities including FDA, EMEA and BfArM.

More recently Andy worked as an interim manager within the Global Pharmacovigilance Department of Norgine Ltd., where he was involved in numerous activities including; the development and implementation of a signal detection process and the supporting cross-functional governance structure, and the management of the single case processing and PSUR writing team. In addition to a BSc in Applied Biology, Andy has a Diploma in Clinical Data Management and a Certificate in Line Management (Institute of Leadership and Management)